Victory Capital Management
SBBP

Victory Capital Management’s Strongbridge Biopharma plc. SBBP Stock Holding History

Victory Capital Management’s Portfolio SBBP Stock Details SBBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-12,780
Closed -$24K – 3606
2020
Q1 		$24K Buy
+12,780
New +$33.2K ﹤0.01% 3049
2019
Q4 		– Sell
-6,633
Closed -$16K – 3580
2019
Q3 		$16K Buy
+6,633
New +$17.8K ﹤0.01% 3127

Other funds holding SBBP

CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Victory Capital Management's SBBP Position: Q2 2020 in Review

Victory Capital Management sold out of Strongbridge Biopharma plc. (SBBP) in Q2 2020, closing a stake of 12,780 shares — an estimated $24K sold.

Victory Capital Management first reported a position in SBBP in Q3 2019 and held it in 2 quarters. The position peaked at $24K in Q1 2020. 69 funds tracked by Wall St. Rank hold SBBP as of Q2 2020.

  • Victory Capital Management reported no remaining Strongbridge Biopharma plc. position as of Q2 2020 after selling out during the quarter.
  • Victory Capital Management sold 12,780 Strongbridge Biopharma plc. shares in Q2 2020, an estimated $24K.
  • Victory Capital Management first reported a position in Strongbridge Biopharma plc. in Q3 2019 and held it in 2 quarters.
  • Victory Capital Management's Strongbridge Biopharma plc. position peaked at $24K in Q1 2020.
  • 69 funds tracked by Wall St. Rank held Strongbridge Biopharma plc. as of Q2 2020.

Based on Victory Capital Management's 13F filing for Q2 2020, filed 7 Aug 2020.